---
schema_version: "secwatch.filing_event.v1"
accession: "0000059478-23-000160"
form_type: "8-K"
ticker: "LLY"
cik: "0000059478"
company_name: "ELI LILLY & Co"
filed_at: "2023-04-27T23:59:59+00:00"
generated_at: "2026-06-16T09:49:48.192738+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Lilly Q1 revenue $6.96B (-11%); EPS $1.49 (-29%); core biz ex-COVID +10%; guidance raised

## Summary
- Revenue $6.96B, down 11% YoY; ex-COVID-19 antibodies up 10% on Mounjaro, Trulicity, Verzenio, Jardiance.
- Reported EPS $1.49, down 29%; non-GAAP EPS $1.62, down 38%; both include $0.10 acquired IPR&D.
- 2023 reported EPS guidance raised to $8.18-$8.38; non-GAAP to $8.65-$8.85 (up $0.30).
- New Products (Mounjaro, Jaypirca) contributed $573.6M; Growth Products rev $4.56B (+18%).

## SEC filing metadata
- accession: 0000059478-23-000160
- form_type: 8-K
- ticker: LLY
- cik: 0000059478
- company_name: ELI LILLY & Co
- filed_at: 2023-04-27T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/59478/000005947823000160/0000059478-23-000160-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/59478/000005947823000160/lly-20230427.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000059478-23-000160
- JSON: https://secwatch.observer/filing/0000059478-23-000160.json
- Plain text: https://secwatch.observer/filing/0000059478-23-000160.txt

## Key facts
- Earnings Releases
  ELI LILLY & Co reported First Quarter 2023 results: revenue $6,960.0, net income $1,344.9, EPS $1.49. Guidance raised.
  - Period: First Quarter 2023
  - Revenue: $6,960.0
  - Net income: $1,344.9
  - EPS: $1.49
  - Guidance: raised
  - Result: reported results
  source text: Financial Results $ in millions, except per share data First Quarter 2023 2022 % Change Revenue $6,960.0 $7,810.0 (11)% Net Income – Reported 1,344.9 1,902.9 (29)% EPS – Reported 1.49 2.10 (29)% Net Income – Non-GAAP 1,463.9 2,372.8 (38)% EPS – Non-GAAP 1.62 2.62 (38)%
  evidence_url: https://www.sec.gov/Archives/edgar/data/59478/000005947823000160/0000059478-23-000160-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.